Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Adhoute

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Chinese Clinical Oncology|December 22, 2025
Nonsurgical hepatocellular carcinoma treated with selective internal radiation therapy and personalized dosimetry: real-life data from French centersLouis Carmarans, Claude Somma, Victoria Ramdour, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and PrognosisXavier Adhoute, Olivia Pietri, Guillaume Pénaranda, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2015
Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter studyXavier Adhoute, Guillaume Pénaranda, Jean L Raoul, et al.
European Journal of Gastroenterology & Hepatology|February 15, 2017
NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolizationXavier Adhoute, Guillaume Pénaranda, Jean Luc Raoul, et al.
Journal of Viral Hepatitis|May 21, 2025
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO StudySi Ahmed Si Nafa, Souad Benali, Guillaume Penaranda, et al.
World Journal of Gastroenterology|May 4, 2017
Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortXavier Adhoute, Guillaume Pénaranda, Jean Luc Raoul, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2025
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY DataHéloïse Bourien, Xavier Adhoute, Boris Campillo-Gimenez, et al.
Nature Communications|August 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically activeCelia Sequera, Margherita Grattarola, Floriane Cannet, et al.
Cancers|April 13, 2023
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II StudyCaroline Gronnier, Christophe Mariette, Come Lepage, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Chinese Clinical Oncology|December 22, 2025
Nonsurgical hepatocellular carcinoma treated with selective internal radiation therapy and personalized dosimetry: real-life data from French centersLouis Carmarans, Claude Somma, Victoria Ramdour, et al.
Journal of Clinical and Translational Hepatology|August 14, 2023
Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and PrognosisXavier Adhoute, Olivia Pietri, Guillaume Pénaranda, et al.
European Journal of Gastroenterology & Hepatology|December 24, 2015
Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter studyXavier Adhoute, Guillaume Pénaranda, Jean L Raoul, et al.
European Journal of Gastroenterology & Hepatology|February 15, 2017
NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolizationXavier Adhoute, Guillaume Pénaranda, Jean Luc Raoul, et al.
Journal of Viral Hepatitis|May 21, 2025
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO StudySi Ahmed Si Nafa, Souad Benali, Guillaume Penaranda, et al.
World Journal of Gastroenterology|May 4, 2017
Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortXavier Adhoute, Guillaume Pénaranda, Jean Luc Raoul, et al.
Journal of Gastroenterology and Hepatology|May 8, 2019
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer stagingTung-Hung Su, Sih-Han Liao, Chun-Ming Hong, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2025
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY DataHéloïse Bourien, Xavier Adhoute, Boris Campillo-Gimenez, et al.
Nature Communications|August 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically activeCelia Sequera, Margherita Grattarola, Floriane Cannet, et al.
Cancers|April 13, 2023
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II StudyCaroline Gronnier, Christophe Mariette, Come Lepage, et al.
Pageof 7